Publications » 2001

Show per page  
Publications indexed in Scopus database
81*Ignatovich L.; Zariņa D.; Shestakova I.; Germane S.; Lukevics E. Synthesis and biological activity of silyl- and germylsubstituted trifluoroacetylfurans. Met.-Based Drugs 2001, 8(4), 211-214.      

82*Markava E.; Gustiņa D.; Muzikante I.; Gerca L.; Rutkis M.; Fonavs E. Photochromism of some azobenzene derivatives in thin films as a function of the chemical properties of the molecule. Mol Cryst Liq Cryst Sci Technol Sect A Mol Crys Liq Cryst 2001, 355, 381-400.      

83*Markava E.; Gustiņa D.; Muzikante I. Optically induced azo-hydrazone tautomerism of some 2,6-dialkylphenol based azobenzenes. Proc SPIE Int Soc Opt Eng 2001, 4415, 162-167.      

84*Krauze A.; Garalene V.; Vitolina R.; Duburs G. Synthesis of 4,5-dipyridylpyridin-2(1H)-ones, pyridine-2(1H)-thiones and related derivatives as analoges of cardiotonic drug milrinone. Heterocycl. Commun. 2001, 7(5), 427-432.      

85*Lukevics E.; Ignatovich L.; Belyakov S. The crystal structure of dichloromethylgermatrane. Main Group Met. Chem. 2001, 24(12), 869-870.      

86*Lukevics E.; Arsenyan P.; Belyakov S.; Pudova O. The crystal structure of dimethylvinylsiloxygermatrane. Main Group Met. Chem. 2001, 24(4), 253-254.      

87*Ābele E.; Lukevics E. Synthesis of sterically hindered heteroaromatic ketones under phase-transfer and metal-complex catalysis conditions. (Review). Chem. Heterocycl. Compd. 2001, 37(1), 5-14.      

88*Ābele E.; Lukevics E. Recent advances in fluoride ion activation of silicon bonds in organic synthesis. Main Group Met. Chem. 2001, 24(6), 315-350.      

89Rubina K.; Ābele E.; Arsenyan P.; Abele R.; Vēveris M.; *Lukevics E. Synthesis of silicon and germanium containing heteroaromatic sulfides as cholesterol level lowering and vasodilating agents. Met.-Based Drugs 2001, 8(2), 85-93.      

90Ābele E.; *Rubina K.; Abele R.; Dzenitis O.; Arsenyan P.; Popelis J.; Vēveris M.; Meirena D.; Lukevics E. Silacyclic derivatives of heteroaromatic sulfides as selective cholesterol level lowering and vasodilating agents. Met.-Based Drugs 2001, 8(6), 307-313.      

Show per page